Opendata, web and dolomites

ClearPEMplus

Enhanced Silicon Photomultiplier-based detectors for high-resolution Positron Emission Mammography.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ClearPEMplus project word cloud

Explore the words cloud of the ClearPEMplus project. It provides you a very rough idea of what is the project "ClearPEMplus" about.

false    healthcare    situations    replying    exact    device    critical    business       specificity    asics    lesions    clinics    scarce    technique    chain    sound    planning    trials    extreme    industrialization    breast    supply    rate    cure    dense    unnecessary    petsys    women    read    positive    staging    complement    outcome    tailoring    screening    young    history    tumor    removal    cancer    imaging    implies    housing    million    suffer    operation    implants    model    exams    clinical    effect    fold    survival    detection    localization    light    larger    clearpem    market    solid    mm    spatial    single    scanners    module    signal    positron    additional    sensitivity    designed    beneficial    complete    detector    plan    performing    tumours    mammography    body    enhanced    sipm    small    5cm    hospital    establishing    battle    tomography    departments    scanner    pet    resolution    elaboration    innovative    marketing    commercialization    strategy    emission    hospitals    photodetector    electronics    detecting    silicon    distress    circuits   

Project "ClearPEMplus" data sheet

The following table provides information about the project.

Coordinator
PETSYS ELECTRONICS - MEDICAL PET DETECTORS SA 

Organization address
address: TAGUSPARK EDIFICIO TECNOLOGIA I 26
city: PORTO SALVO
postcode: 2740 122
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://www.petsyselectronics.pt
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PETSYS ELECTRONICS - MEDICAL PET DETECTORS SA PT (PORTO SALVO) coordinator 50˙000.00

Map

 Project objective

Breast cancer affects more than 1.7 million women each year in Europe. Early detection and exact staging (single or multi-localization) is of extreme importance for improving the survival rate and cure outcome, and tailoring the operation (tumor or whole-breast removal). Currently mammography is the technique of choice for breast cancer screening, with positive cases addressed to further exams. Positron Emission Tomography (PET) imaging is beneficial to complement mammography in many situations: screening of critical cases with cancer history, detection in young women with dense breast or silicon implants, and to evaluate the effect of a cure. However whole-body PET scanners suffer of scarce sensitivity and are effective only in detecting tumours larger than 1-1.5cm. PETsys Electronics has designed and developed an innovative detector module for PET scanner based on the SiPM photodetector, a solid state device with enhanced sensitivity to low–light signal, that is read out by their novel highly integrated Application Specific Integrated Circuits (ASICs). The housing is specifically designed for breast cancer detection. Currently, ClearPEM is the only PET breast scanner based on the SiPM photodetector, which allows to provide a 10-fold larger sensitivity than whole body PET scanner. The improved spatial resolution enables to identify breast lesions as small as 1-2 mm. ClearPEM addresses the market of hospitals and clinics replying to their need of enhancing the specificity of mammography screening in breast cancer detection to battle the increasing rate of false-positive results, which implies additional cost for the healthcare system and unnecessary distress for women. The Phase 1 project will be focused on establishing a complete supply chain, a sound business model and commercialization strategy, a planning of all activities for performing the clinical trials in hospital departments, as well as the elaboration of an industrialization and marketing plan.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLEARPEMPLUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLEARPEMPLUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

VANGUARD (2020)

New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes

Read More